VariClose® vein sealing system is inferior to endovenous laser ablation for the treatment of varicose veins

Vascular. 2022 Jun;30(3):542-547. doi: 10.1177/17085381211013975. Epub 2021 May 22.

Abstract

Background: One of the three commercially available cyanoacrylate venous glues used for the treatment of saphenous vein insufficiency is the VariClose® vein sealing system. Previous studies have documented a high rate of occlusion and minimal postoperative complications. The aim of this study was to compare occlusion rates and clinical outcomes of endovenous laser treatment with the VariClose® vein sealing system in the treatment of truncal vein insufficiency.

Patients and methods: Retrospective non-randomized single center study with prospectively collected data comparing endovenous laser treatment and VariClose® procedures between April 2018 and November 2019.

Results: VariClose® was used in 27 patients (30 veins) and endovenous laser treatment in 42 patients (51 veins). The occlusion rate at one, three, and six months were 96%, 85%, and 65% for VariClose® procedures and 100%, 100%, and 97% for endovenous laser treatment procedures (p = 0.01), respectively. Reduction of VCSS scores before treatment and at the last postoperative follow-up visit in the VariClose® group dropped by an average of 1.8 ± 1.6 and in the endovenous laser treatment by an average of 3.3 ± 2.9 (p = 0.01).

Conclusion: VariClose® vein sealing system is inferior to endovenous laser treatment as a treatment option for varicose veins as it has a higher recanalization rate.

Keywords: Cyanoacrylate ablation; VariClose®; endovenous laser; varicose vein; venous insufficiency.

MeSH terms

  • Humans
  • Laser Therapy* / adverse effects
  • Laser Therapy* / methods
  • Retrospective Studies
  • Saphenous Vein / diagnostic imaging
  • Saphenous Vein / surgery
  • Treatment Outcome
  • Varicose Veins* / diagnostic imaging
  • Varicose Veins* / surgery
  • Venous Insufficiency* / diagnostic imaging
  • Venous Insufficiency* / surgery